Navigation Links
Over 70 Percent of Physicians Say There Is a High Need for More Diabetes Drugs with Novel Mechanisms of Action While 15 Percent Say the Same for DPP-IV Inhibitors
Date:12/17/2009

tes treatment, likely because of their familiarity with and comfort prescribing Byetta (Byetta LAR has the same active molecule as Byetta) and their opinion that Byetta LAR (once-weekly injection) offers substantial dosing advantage over Victoza (once-daily injection)," added Dr. Westphal.

The report contains primary research based on a survey of 148 U.S. physicians and 336 U.S. patients. Key brands included in the primary research consist of Byetta; Takeda's Actos, ACTOplus met and Duetact; GlaxoSmithKline's Avandia, Avandamet and Avandaryl; Merck's Januvia and Janumet; and Bristol-Myers Squibb/AstraZeneca/Otsuka's Onglyza.

About Brand Perception Series

Decision Resources' Brand Perception Series quantitatively analyzes physician and patient brand perception of current and emerging therapies and identifies key physician and patient segments to help clients identify high opportunity targets. The findings are driven by extensive primary research and offer clients an unbiased, comprehensive, cost-effective solution to understanding the full competitive brand landscape.

About Decision Resources

Decision Resources (www.DecisionResources.com) is a world leader in market research publications, advisory services and consulting designed to help clients shape strategy, allocate resources and master their chosen markets. Decision Resources is a Decision Resources, Inc. company.

About Decision Resources, Inc.

Decision Resources, Inc. is a cohesive portfolio of companies that offers best-in-class, high-value information and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed decisions. Please visit D
'/>"/>

SOURCE Decision Resources
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Patent Expiries of Blockbuster Antibiotics Will Fuel a Decline of More Than 15 Percent in the Community-Acquired Pneumonia Drug Market
2. $232 Billion Personalized Medicine Market to Grow 11 Percent Annually, says PricewaterhouseCoopers
3. Russias Hepatitis C Virus Drug Market Will Grow Nine Percent Annually, Reaching $327 Million by 2013
4. Sales of HER2-Targeting Agents for Breast Cancer, Including Herceptin and Tykerb/Tyverb, Will Grow by 3.3 Percent Annually from 2008 to 2018
5. Thoratec Reports 14 Percent Growth in Cardiovascular Division Sales as Third Quarter Revenues Increase Nine Percent
6. Ninety Eight Percent of Surveyed Rheumatologists Will Prescribe Roches Actemra for Rheumatoid Arthritis
7. Burton Medicals New Diagnostic Examination Light, the AIM LED Provides 10 Percent More Illumination and 10 Times Greater Lamp Life
8. Accurays Treatment Planning Service Active at 20 Percent of U.S. CyberKnife Centers
9. Dartmouth Medical School Faculty Member and Anesthesiologist Invents Revolutionary Catheter System Designed to Increase Rate of Successful IV Insertions by 75 Percent
10. Second-Generation Female Condom is Now Available in the United States; FC2 Female Condom Will Cost 30 Percent Less than Predecessor
11. Abbott Cuts Use of Oil and Coal by 35 Percent
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... , Aug. 29, 2014  United Therapeutics Corporation (NASDAQ: ... District Court for the District of New ... the company,s case against Sandoz, Inc. regarding United Therapeutics, ... Sheridan ruled that U.S. Patent No. 6,765,117 is ... Sandoz from marketing its generic product until the expiration ...
(Date:8/29/2014)... Aug. 29, 2014 /PRNewswire-iReach/ -- ChemImage will present a ... and New Zealand Forensic Science Society,s 22 nd ... Adelaide, Australia .  Forensic Scientists ... advancements that hyperspectral imaging can bring to examination ... , Director of Product Development at ChemImage, will ...
(Date:8/29/2014)... MENLO PARK, Calif. , Aug. 29, 2014 ... DMPI) ("DelMar" "the Company") today announced the filing of ... recently changed its fiscal year end to June 30th ... common stock on a national securities exchange in the ... filed with the United States Securities Exchange Commission can ...
Breaking Medicine Technology:District Court Decision Received In Remodulin Patent Case 2ChemImage to Discuss Hyperspectral Imaging for Forensic Investigation at the ANZFSS 22nd International Symposium on the Forensic Sciences 2ChemImage to Discuss Hyperspectral Imaging for Forensic Investigation at the ANZFSS 22nd International Symposium on the Forensic Sciences 3DelMar Pharmaceuticals Fiscal 2014 Year End Results and Summary of Recent Developments 2DelMar Pharmaceuticals Fiscal 2014 Year End Results and Summary of Recent Developments 3DelMar Pharmaceuticals Fiscal 2014 Year End Results and Summary of Recent Developments 4DelMar Pharmaceuticals Fiscal 2014 Year End Results and Summary of Recent Developments 5
... 1, 2012 Heart IT, the global leader ... medical imaging workstation, WebPAX®, announced today the award ... viewing technologies. "Zero-footprint" technologies allow health care professionals ... with a standard Internet web browser. ...
... (NASDAQ: ANGN ) today announced it has ... Global Sales effective May 7, 2012. Mr. Margolies will ... worldwide sales organization and delivering sales results to achieve ... Mr. Margolies will be succeeding James Gaul, senior vice ...
Cached Medicine Technology:U.S. Patent Office Issues Sixth Patent Covering 'Zero-Footprint' Medical Image Viewers to Heart Imaging Technologies, LLC 2Angeion Appoints Matthew S. Margolies as Executive Vice President - Global Sales 2Angeion Appoints Matthew S. Margolies as Executive Vice President - Global Sales 3Angeion Appoints Matthew S. Margolies as Executive Vice President - Global Sales 4
(Date:9/1/2014)... Beginning Tuesday, September 2nd, Las Vegas will ... 10,000 consumers for the annual gathering known as Pain ... nation’s top medical professionals who specializes in chronic pain ... event contains more than 120 hours of the most ... pain management field. , MarijuanaDoctors.com is pleased to announce ...
(Date:8/31/2014)... MYMOBILEUNI (MMU) strategy is to outreach ... tools access to digital, resources, courses, videos, audio ... tools to reach and collaborate with educational institutions ... channels. , MMU, today announced the availability of ... that applies social networking concepts to the learning ...
(Date:8/31/2014)... (PRWEB) September 01, 2014 GoDaddy, ... companies that provide VPS (Virtual Private Server) hosting, ... server computer into many servers, each of which ... someone’s own dedicated computer. Top10BestSEOHosting.com has recently compared ... these three companies are the best VPS hosting ...
(Date:8/31/2014)... In order to celebrate the coming of autumn, Guangdong ... and launched a big promotion. Now, all the global clients ... company’s new cars are made with great materials. FODAY Automobile ... As a matter of fact, it is providing big discounts ... in need of cheap cars can visit its website for ...
(Date:8/31/2014)... 31, 2014 In the wake of ... have proposed legislation to require mandatory labeling of GMOs ... informed purchasing decisions that affect their own health and ... advocating for stringent measures to eliminate GMOs from dietary ... Communication, Engagement” (I.C.E.) initiative with the objective of advancing ...
Breaking Medicine News(10 mins):Health News:Medical Marijuana Doctor Company Set to Present at Las Vegas Pain Week 2Health News:My Mobile University Announces Global Strategic Plan and Unveils New Android App to Enhance and Impact Lives World-Wide Through Education for All as Learning Platform 2Health News:My Mobile University Announces Global Strategic Plan and Unveils New Android App to Enhance and Impact Lives World-Wide Through Education for All as Learning Platform 3Health News:GoDaddy, IX Web Hosting and Bluehost Are Awarded As Hosting Experts by Top10BestSEOHosting.com 2Health News:NutriGold Announces its I.C.E. Initiative to Educate Consumers about GMOs in Dietary Supplements 2Health News:NutriGold Announces its I.C.E. Initiative to Educate Consumers about GMOs in Dietary Supplements 3
... majority of advanced colon cancer patients in a clinical ... drugs for managing chemotherapy side effects, such as infection, ... drug cost burdens after joining the clinical trial, according ... Institute in Boston. Although few patients reported substantial worry ...
... -- PRA International, a leading Clinical Research ... audioconference and announces it will exhibit at the 2009 ... Florida, May 30 through June 1. The audioconference, which ... 2009, and was presented by John Constant, PhD, PRA,s ...
... U.S. Food and Drug Administration (FDA) announced today that ... for Pharmaceutical Science and Clinical Pharmacology to discuss bioequivalence ... The meeting is scheduled for August 4, 2009. ... no later than two days before the meeting at ...
... 29 The J. Craig Venter Institute (JCVI) announced ... five year contract from the National Institute of Allergy ... of Health, as one of their Genomic Sequencing Centers ... Nierman, Ph.D., and Robert Strausberg, Ph.D., the contract will ...
... DeterminedToQuit.com translated to Estoydecidido.com for Latino PennsylvaniansHARRISBURG, ... Health Everette James today announced the launch ... Latino residents of Pennsylvania go tobacco free.Estoydecidido.com ... - is the Spanish version of the ...
... finds student military veterans face some unique health issuesMINNEAPOLIS/ST. ... expected to go to school this fall as a ... will need to ensure student veterans, unique needs are ... issued Friday by the University of Minnesota ...
Cached Medicine News:Health News:One in ten advanced colon cancer patients worry about prescription drug costs 2Health News:PRA International Oncology Experts at ASCO 2Health News:ViroPharma Announces Meeting of FDA Advisory Committee for Pharmaceutical Science and Clinical Pharmacology on Bioequivalence Recommendations for Oral Vancomycin Hydrochloride Products 2Health News:ViroPharma Announces Meeting of FDA Advisory Committee for Pharmaceutical Science and Clinical Pharmacology on Bioequivalence Recommendations for Oral Vancomycin Hydrochloride Products 3Health News:ViroPharma Announces Meeting of FDA Advisory Committee for Pharmaceutical Science and Clinical Pharmacology on Bioequivalence Recommendations for Oral Vancomycin Hydrochloride Products 4Health News:J. Craig Venter Institute Awarded $43 Million, Five Year Contract From NIAID to Continue to Develop and Provide Sequencing, Genotyping, and Bioinformatics Expertise and Services in Infectious Diseases 2Health News:J. Craig Venter Institute Awarded $43 Million, Five Year Contract From NIAID to Continue to Develop and Provide Sequencing, Genotyping, and Bioinformatics Expertise and Services in Infectious Diseases 3Health News:PA Department of Health Launches Spanish-Language Smoking Cessation Resource Web Site 2Health News:Student Veteran Health Examined in First-of-Its-Kind Study by University of Minnesota/Minnesota State Colleges and Universities 2Health News:Student Veteran Health Examined in First-of-Its-Kind Study by University of Minnesota/Minnesota State Colleges and Universities 3
... to provide excellent protection and ease of ... being closer to an adhesive in molecular ... CoEase to maintain viscosity at high shear ... worlds for superb performance during capsulorhexis, phaco, ...
... PROVISC ophthalmic viscosurgical device is ... characterized by high molecular weight, ... tension. It provides excellent space ... is easily removed. It is ...
... permit fundus imaging and documentation of ... any need for eyepieces guarantees the ... recording and display is an entirely ... ophthalmoscope principle of modern fundus cameras. ...
... The ARIS A utomated R ... revolutionary, patented technology which provides rapid and automated ... allows eye care professionals to screen and ... in less time and at ...
Medicine Products: